Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-08

Clinical Trial Update: Guanfacine in Children With Tic Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial update on guanfacine in children with tic disorders (Tourette Disorder/Tourette Syndrome) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

Sponsor: Yale University | Conditions: Tourette Disorder, Tourette Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2018-06-08